Skip to Content

Tag: Perforomist

Specialty Providers

ASP: Budesonide reverses course

December 11, 2013HME News Staff

BALTIMORE - When it comes to nebulizer medication pricing, one quarter you're up; another quarter you're down.Average sales price (ASP) figures for the first quarter of 2014 revealed a decrease for budesonide (J7626) of nearly 35 cents to $5.60 per dose. That's in contrast to the previous quarter, when the drug increased 85 cents.The only other drugs to see increases for the upcoming quarter: brand names Brovana (J7605) and Perforomist (J7606), which increased 22 cents and 6 cents, respectively....

Albuterol, Average Sales Price, Brovana, Budesonide, Ipratropium, Neb meds, Perforomist

Read Full Articlered right arrow icon

Specialty Providers

Prices, audits stay the course

April 23, 2012Theresa Flaherty, Managing Editor

BALTIMORE - Brand-name Brovana took a hit in the latest average sales price (ASP) figures for nebulizer medications, but otherwise there were few major changes.The long-acting beta agonist Brovana (J7605) decreased 24 cents to $5.11 per dose in the latest figures, released in March.Between the lower reimbursement and a price increase from the manufacturer, you won't see many providers supplying the drug, said Sam Jarczynski, who blames market consolidation for the change.“There are so few respiratory...

Albuterol, Average Sales Prices, Brovana, Budesonide, neb-meds, Perforomist

Read Full Articlered right arrow icon